Selfie: Autoimmunity, boon or bane
- PMID: 28421864
- DOI: 10.1080/15321819.2017.1319861
Selfie: Autoimmunity, boon or bane
Abstract
The immune system provides protection to tissues damaged by infectious microrganisms or physical damage. In autoimmune diseases, the immune system recognizes and attacks its own tissues, i.e., self-destruction. Various agents such as genetic factors and environmental triggers are thought to play a major role in the development of autoimmune diseases. A common feature of all autoimmune diseases is the presence of autoantibodies and inflammation, including mononuclear phagocytes, autoreactive T lymphocytes, and autoantibody producing B cells (plasma cells). It has long been known that B cells produce autoantibodies and, thereby, contribute to the pathogenesis of many autoimmune diseases. Autoimmune diseases can be classified as organ-specific or non-organ specific depending on whether the autoimmune response is directed against a particular tissue or against widespread antigens as in chronic inflammatory autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Both SLE and RA are characterized by the presence of autoantibodies which play a major role in their etiopathogenesis. SLE is characterized by circulating antibodies and immune complex deposition that can trigger an inflammatory damage in organs. RA is a progressive inflammatory disease in which T cells, B cells, and pro-inflammatory cytokines play a key role in its pathophysiology.
Keywords: Autoimmunity; autoantibodies; autoantigens; rheumatoid arthritis; systemic lupus erythematosus.
Similar articles
-
The immunological basis of B-cell therapy in systemic lupus erythematosus.Int J Rheum Dis. 2010 Feb 1;13(1):3-11. doi: 10.1111/j.1756-185X.2009.01458.x. Int J Rheum Dis. 2010. PMID: 20374380 Review.
-
Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.J Rheumatol Suppl. 2006 May;77:3-11. J Rheumatol Suppl. 2006. PMID: 16652439 Review.
-
[The role of the PD-1 protein in pathogenesis of autoimmune diseases, with particular consideration of rheumatoid arthritis and systemic lupus erythematosus].Postepy Hig Med Dosw (Online). 2015 Apr 28;69:534-42. doi: 10.5604/17322693.1150784. Postepy Hig Med Dosw (Online). 2015. PMID: 25983292 Polish.
-
The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.J Autoimmun. 2016 Nov;74:118-138. doi: 10.1016/j.jaut.2016.06.020. Epub 2016 Jul 6. J Autoimmun. 2016. PMID: 27396525 Review.
-
[The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].Z Rheumatol. 2001 Feb;60(1):1-16. doi: 10.1007/s003930170093. Z Rheumatol. 2001. PMID: 11263010 Review. German.
Cited by
-
The Oral Microbiome and Its Role in Systemic Autoimmune Diseases: A Systematic Review of Big Data Analysis.Front Big Data. 2022 Jun 29;5:927520. doi: 10.3389/fdata.2022.927520. eCollection 2022. Front Big Data. 2022. PMID: 35844967 Free PMC article.
-
Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases.Dokl Biochem Biophys. 2024 Aug;517(1):228-234. doi: 10.1134/S1607672924700959. Epub 2024 Jul 13. Dokl Biochem Biophys. 2024. PMID: 39002011
-
Anti-Idiotypic mRNA Vaccine to Treat Autoimmune Disorders.Vaccines (Basel). 2023 Dec 21;12(1):9. doi: 10.3390/vaccines12010009. Vaccines (Basel). 2023. PMID: 38276668 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical